AAAAAA

   
Results: 1-10 |
Results: 10
Xenopus phospho-CDK7/cyclin H expressed in baculoviral-infected insect cells
Authors: Lawrie, AM Tito, P Hernandez, H Brown, NR Robinson, CV Endicott, JA Noble, MEM Johnson, LN
Citation: Am. Lawrie et al., Xenopus phospho-CDK7/cyclin H expressed in baculoviral-infected insect cells, PROT EX PUR, 23(2), 2001, pp. 252-260
Inhibitor binding to active and inactive CDK2: The crystal structure of CDK2-cyclin A/indirubin-5-sulphonate
Authors: Davies, TG Tunnah, P Meijer, L Marko, D Eisenbrand, G Endicott, JA Noble, MEM
Citation: Tg. Davies et al., Inhibitor binding to active and inactive CDK2: The crystal structure of CDK2-cyclin A/indirubin-5-sulphonate, STRUCTURE, 9(5), 2001, pp. 389-397
Identification of novel purine and pyrimidine cyclin-dependent kinase inhibitors with distinct molecular interactions and tumor cell growth inhibition profiles
Authors: Arris, CE Boyle, FT Calvert, AH Curtin, NJ Endicott, JA Garman, EF Gibson, AE Golding, BT Grant, S Griffin, RJ Jewsbury, P Johnson, LN Lawrie, AM Newell, DR Noble, MEM Sausville, EA Schultz, R Yu, W
Citation: Ce. Arris et al., Identification of novel purine and pyrimidine cyclin-dependent kinase inhibitors with distinct molecular interactions and tumor cell growth inhibition profiles, J MED CHEM, 43(15), 2000, pp. 2797-2804
The structural basis for specificity of substrate and recruitment peptidesfor cyclin-dependent kinases
Authors: Brown, NR Noble, MEM Endicott, JA Johnson, LN
Citation: Nr. Brown et al., The structural basis for specificity of substrate and recruitment peptidesfor cyclin-dependent kinases, NAT CELL BI, 1(7), 1999, pp. 438-443
Indirubin, the active constituent of a Chinese antileukaemia medicine, inhibits cyclin-dependent kinases
Authors: Hoessel, R Leclerc, S Endicott, JA Nobel, MEM Lawrie, A Tunnah, P Leost, M Damiens, E Marie, D Marko, D Niederberger, E Tang, WC Eisenbrand, G Meijer, L
Citation: R. Hoessel et al., Indirubin, the active constituent of a Chinese antileukaemia medicine, inhibits cyclin-dependent kinases, NAT CELL BI, 1(1), 1999, pp. 60-67
Cyclin-dependent kinases: inhibition and substrate recognition
Authors: Endicott, JA Noble, MEM Tucker, JA
Citation: Ja. Endicott et al., Cyclin-dependent kinases: inhibition and substrate recognition, CURR OP STR, 9(6), 1999, pp. 738-744
Signal transduction proteins: Structural basis of control by phosphorylation
Authors: Johnson, LN Noble, MEM Barford, D Brown, N Endicott, JA Lawrie, A Owen, DJ
Citation: Ln. Johnson et al., Signal transduction proteins: Structural basis of control by phosphorylation, J CHEM S P, 21(3), 1999, pp. 185-201
Chemical inhibitors of cyclin-dependent kinases: Insights into design fromX-ray crystallographic studies
Authors: Noble, MEM Endicott, JA
Citation: Mem. Noble et Ja. Endicott, Chemical inhibitors of cyclin-dependent kinases: Insights into design fromX-ray crystallographic studies, PHARM THERA, 82(2-3), 1999, pp. 269-278
Effects of phosphorylation of threonine 160 on cyclin-dependent kinase 2 structure and activity
Authors: Brown, NR Noble, MEM Lawrie, AM Morris, MC Tunnah, P Divita, G Johnson, LN Endicott, JA
Citation: Nr. Brown et al., Effects of phosphorylation of threonine 160 on cyclin-dependent kinase 2 structure and activity, J BIOL CHEM, 274(13), 1999, pp. 8746-8756
"Ich-bin-viel-zu-selbstkritisch" - An interview with Josephine Ann Endicott
Authors: Regitz, H Endicott, JA
Citation: H. Regitz et Ja. Endicott, "Ich-bin-viel-zu-selbstkritisch" - An interview with Josephine Ann Endicott, BALLETT INT, (8-9), 1998, pp. 50-55
Risultati: 1-10 |